bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 9, 2023
Abstract
The
progression
of
kidney
disease
varies
among
individuals,
but
a
general
methodology
to
quantify
timelines
is
lacking.
Particularly
challenging
the
task
determining
potential
for
recovery
from
acute
injury
following
various
insults.
Here,
we
report
that
quantitation
post-transcriptional
adenosine-to-inosine
(A-to-I)
RNA
editing
offers
distinct
genome-wide
signature,
enabling
delineation
trajectories
in
kidney.
A
well-defined
murine
model
endotoxemia
permitted
identification
origin
and
extent
A-to-I
editing,
along
with
temporally
discrete
signatures
double-stranded
stress
Adenosine
Deaminase
isoform
switching.
We
found
Antizyme
Inhibitor
1
(AZIN1),
positive
regulator
polyamine
biosynthesis,
serves
as
particularly
useful
temporal
landmark
during
endotoxemia.
Our
data
indicate
AZIN1
triggered
by
preceding
inflammation,
primes
activates
endogenous
mechanisms.
By
comparing
genetically
modified
human
cell
lines
mice
locked
either
edited
or
uneditable
states,
uncovered
not
only
enhances
biosynthesis
also
engages
glycolysis
nicotinamide
drive
phenotype.
findings
implicate
quantifying
could
potentially
identify
individuals
who
have
transitioned
an
phase.
This
phase
would
reflect
their
past
inflammation
future
recovery.
Kidney International,
Journal Year:
2024,
Volume and Issue:
106(1), P. 24 - 34
Published: April 16, 2024
Kidney
epithelial
cells
have
very
high
energy
requirements,
which
are
largely
met
by
fatty
acid
oxidation.
Complex
changes
in
lipid
metabolism
observed
patients
with
kidney
disease.
Defects
oxidation
and
increased
uptake,
especially
the
context
of
hyperlipidemia
proteinuria,
contribute
to
this
excess
build-up
exacerbate
disease
development.
Recent
studies
also
highlighted
role
de
novo
lipogenesis
fibrosis.
The
defect
causes
starvation.
Increased
synthesis,
lower
can
cause
toxic
build-up,
reactive
oxygen
species
generation,
mitochondrial
damage.
A
better
understanding
these
metabolic
processes
may
open
new
treatment
avenues
for
diseases
targeting
metabolism.
Renal Failure,
Journal Year:
2025,
Volume and Issue:
47(1)
Published: Feb. 27, 2025
Background
Recent
studies
innovatively
revealed
the
localized
expression
of
complement
genes
in
kidneys
and
shed
light
on
vital
roles
intracellular
system
physiologic
function
pathological
conditions.
However,
a
comprehensive
analysis
context
evolving
cellular
landscape
kidney
is
not
available.
Journal of Clinical Investigation,
Journal Year:
2025,
Volume and Issue:
135(6)
Published: March 16, 2025
Acute
kidney
injury
(AKI)
encompasses
pathophysiology
ranging
from
glomerular
hypofiltration
to
tubular
cell
and
outflow
obstruction.
This
Review
will
focus
on
the
tubulointerstitial
processes
that
underlie
most
cases
of
AKI.
Tubular
epithelial
(TEC)
can
occur
via
distinct
insults,
including
ischemia,
nephrotoxins,
sepsis,
primary
immune-mediated
processes.
Following
these
initial
cells
activate
survival
repair
responses
or
they
develop
mitochondrial
dysfunction
metabolic
reprogramming,
cell-cycle
arrest,
programmed
death.
Developing
evidence
suggests
fate
individual
survive
proliferate
undergo
death
senescence
is
frequently
determined
by
a
biphasic
immune
response
with
proinflammatory
macrophage,
neutrophil,
lymphocyte
infiltration
exacerbating
activating
death,
while
alternatively
activated
macrophages
specific
subsets
subsequently
modulate
inflammation
promote
repair.
Functional
recovery
requires
this
reparative
phase
supports
proteolytic
degradation
casts,
proliferation
surviving
TECs,
restoration
TEC
differentiation.
Incomplete
resolution
persistence
lead
failed
repair,
fibrosis,
chronic
disease.
Despite
extensive
research
in
animal
models,
translating
preclinical
findings
therapies
remains
challenging,
emphasizing
need
for
integrated
multiomic
approaches
advance
AKI
understanding
treatment.
Journal of Diabetes Research,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Diabetes
is
a
systemic
metabolic
disorder
primarily
caused
by
insulin
deficiency
and
resistance,
leading
to
chronic
hyperglycemia.
Prolonged
diabetes
can
result
in
damage
multiple
organs,
including
the
heart,
brain,
liver,
muscles,
adipose
tissue,
thereby
causing
various
fatal
complications
such
as
diabetic
retinopathy,
cardiomyopathy,
nephropathy.
Single‐cell
RNA
sequencing
(scRNA‐seq)
has
emerged
valuable
tool
for
investigating
cell
diversity
pathogenesis
of
identifying
potential
therapeutic
targets
or
complications.
This
review
provides
comprehensive
overview
recent
applications
scRNA‐seq
diabetes‐related
researches
highlights
novel
biomarkers
immunotherapy
with
cell‐type
information
its
associated
Cells,
Journal Year:
2024,
Volume and Issue:
13(5), P. 367 - 367
Published: Feb. 20, 2024
Background:
Fibrosis
is
characterized
by
excessive
extracellular
matrix
formation
in
solid
organs,
disrupting
tissue
architecture
and
function.
The
Y-box
binding
protein-1
(YB-1)
regulates
fibrosis-related
genes
(e.g.,
Col1a1,
Mmp2,
Tgfβ1)
contributes
significantly
to
disease
progression.
This
study
aims
identify
fibrogenic
signatures
the
underlying
signaling
pathways
modulated
YB-1.
Methods:
Transcriptomic
changes
associated
with
gene
patterns
human
chronic
kidney
diseases
murine
acute
injury
models
were
analyzed
a
focus
on
known
YB-1
targets.
Ybx1-knockout
mouse
strains
(Ybx1ΔRosaERT+TX
Ybx1ΔLysM)
subjected
various
models.
histopathological
staining,
transcriptome
analysis,
qRT-PCR,
methylation
zymography,
Western
blotting.
Results:
Integrative
transcriptomic
analyses
revealed
that
involved
several
related
matrisome,
WNT,
YAP/TAZ,
TGFß
pathways,
Klotho
expression.
Changes
status
of
promoter
specific
methyltransferases
(DNMT)
are
linked
expression,
extending
other
genes.
Notably,
kidney-resident
cells
play
significant
role
YB-1-modulated
signaling,
whereas
infiltrating
myeloid
immune
have
minimal
impact.
Conclusions:
emerges
as
master
regulator
fibrogenesis,
guiding
DNMT1
highlights
potential
target
for
epigenetic
therapies
interfering
this
process.
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(17)
Published: July 2, 2024
The
progression
of
kidney
disease
varies
among
individuals,
but
a
general
methodology
to
quantify
timelines
is
lacking.
Particularly
challenging
the
task
determining
potential
for
recovery
from
acute
injury
following
various
insults.
Here,
we
report
that
quantitation
post-transcriptional
adenosine-to-inosine
(A-to-I)
RNA
editing
offers
distinct
genome-wide
signature,
enabling
delineation
trajectories
in
kidney.
A
well-defined
murine
model
endotoxemia
permitted
identification
origin
and
extent
A-to-I
editing,
along
with
temporally
discrete
signatures
double-stranded
stress
adenosine
deaminase
isoform
switching.
We
found
antizyme
inhibitor
1
(AZIN1),
positive
regulator
polyamine
biosynthesis,
serves
as
particularly
useful
temporal
landmark
during
endotoxemia.
Our
data
indicate
AZIN1
triggered
by
preceding
inflammation,
primes
activates
endogenous
mechanisms.
By
comparing
genetically
modified
human
cell
lines
mice
locked
either
A-to-I-edited
or
uneditable
states,
uncovered
not
only
enhances
biosynthesis
also
engages
glycolysis
nicotinamide
drive
phenotype.
findings
implicate
quantifying
could
potentially
identify
individuals
who
have
transitioned
an
phase.
This
phase
would
reflect
their
past
inflammation
future
recovery.